Tokyo Tape
Sign in
← Fuso Pharmaceutical Industries

Annual report

4538.TEDINET S100W3Q0
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
MetricValuePeriodScopeSource row
Revenue¥60.6bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥55.4bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥51.0bn2022-04-01 → 2023-03-31dStandaloneNet sales (5-year summary)
Revenue¥49.6bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥49.3bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income¥4.1bn2024-04-01 → 2025-03-31StandaloneOperating income
Operating income¥2.0bn2023-04-01 → 2024-03-31StandaloneOperating income
Ordinary income¥3.8bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥1.9bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥2.2bn2022-04-01 → 2023-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥2.0bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥2.2bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥5.0bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Profit before tax¥1.8bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Net income−¥3.3bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥1.4bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥1.6bn2022-04-01 → 2023-03-31dStandaloneNet income loss (5-year summary)
Net income¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥1.6bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Total assets¥81.7bnat 2025-03-31StandaloneAssets
Total assets¥75.8bnat 2024-03-31StandaloneAssets
Total assets¥72.5bnat 2023-03-31dStandaloneTotal assets (5-year summary)
Total assets¥69.3bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥69.9bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥48.7bnat 2025-03-31StandaloneLiabilities
Total liabilities¥39.1bnat 2024-03-31StandaloneLiabilities
Net assets / equity¥33.0bnat 2025-03-31StandaloneNet assets
Net assets / equity¥36.7bnat 2024-03-31StandaloneNet assets
Net assets / equity¥35.6bnat 2023-03-31dStandaloneNet assets
Net assets / equity¥34.5bnat 2022-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥33.7bnat 2021-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2025-03-31StandaloneCash and deposits
Cash and deposits¥5.1bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥6.3bnat 2025-03-31StandaloneCash and cash equivalents
Cash & equivalents¥5.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥8.0bnat 2023-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥7.3bnat 2022-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥7.1bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥3.3bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥627m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥2.9bn2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.5bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.2bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.2bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥3.5bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥1.4bn2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.6bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥978m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥7.6bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥14m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥813m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.7bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.4bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-384.952024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥159.982023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥183.072022-04-01 → 2023-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥169.092021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥183.182020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥822024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥702023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥702022-04-01 → 2023-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥602021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥602020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥3,869.1at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,290.55at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,064.76at 2023-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,936.7at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,839.54at 2021-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio40.4%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.4%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.2%at 2023-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio49.8%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio48.2%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE-9.4%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE3.8%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE4.6%2022-04-01 → 2023-03-31dStandaloneRate of return on equity (5-year summary)
ROE4.3%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE4.9%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued9,451,169at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2023-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees1,340at 2025-03-31StandaloneNumber of employees
Employees1,307at 2024-03-31StandaloneNumber of employees
Employees1,314at 2023-03-31dStandaloneNumber of employees
Employees1,344at 2022-03-31dStandaloneNumber of employees
Employees1,356at 2021-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2025-03-311279 pure
Real Estate Businessreportable segmentemployeesat 2025-03-311 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,106
ItemContextValueUnit
Merchandise and finished goodsPrior1YearInstant_NonConsolidatedMember11813000000JPY
Merchandise and finished goodsCurrentYearInstant_NonConsolidatedMember12642000000JPY
Work in processPrior1YearInstant_NonConsolidatedMember49000000JPY
Work in processCurrentYearInstant_NonConsolidatedMember43000000JPY
Raw materials and suppliesPrior1YearInstant_NonConsolidatedMember2340000000JPY
Raw materials and suppliesCurrentYearInstant_NonConsolidatedMember2256000000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember185000000JPY
Advance payments tradeCurrentYearInstant_NonConsolidatedMember283000000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember275000000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember275000000JPY
Other caPrior1YearInstant_NonConsolidatedMember834000000JPY
Other caCurrentYearInstant_NonConsolidatedMember85000000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember44947000000JPY
Current assetsCurrentYearInstant_NonConsolidatedMember48342000000JPY
BuildingsPrior1YearInstant_NonConsolidatedMember34599000000JPY
BuildingsCurrentYearInstant_NonConsolidatedMember34746000000JPY
Accumulated depreciation buildingsPrior1YearInstant_NonConsolidatedMember-24792000000JPY
Accumulated depreciation buildingsCurrentYearInstant_NonConsolidatedMember-25498000000JPY
Buildings netPrior1YearInstant_NonConsolidatedMember9806000000JPY
Buildings netCurrentYearInstant_NonConsolidatedMember9248000000JPY
StructuresPrior1YearInstant_NonConsolidatedMember2205000000JPY
StructuresCurrentYearInstant_NonConsolidatedMember2207000000JPY
Accumulated depreciation structuresPrior1YearInstant_NonConsolidatedMember-1757000000JPY
Accumulated depreciation structuresCurrentYearInstant_NonConsolidatedMember-1795000000JPY
Structures netPrior1YearInstant_NonConsolidatedMember448000000JPY
Structures netCurrentYearInstant_NonConsolidatedMember412000000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember28337000000JPY
Machinery and equipmentCurrentYearInstant_NonConsolidatedMember28640000000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-24004000000JPY
Accumulated depreciation machinery and equipmentCurrentYearInstant_NonConsolidatedMember-24876000000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember4332000000JPY
Machinery and equipment netCurrentYearInstant_NonConsolidatedMember3763000000JPY
VehiclesPrior1YearInstant_NonConsolidatedMember73000000JPY
VehiclesCurrentYearInstant_NonConsolidatedMember76000000JPY
Accumulated depreciation vehiclesPrior1YearInstant_NonConsolidatedMember-61000000JPY
Accumulated depreciation vehiclesCurrentYearInstant_NonConsolidatedMember-62000000JPY
Vehicles netPrior1YearInstant_NonConsolidatedMember12000000JPY
Vehicles netCurrentYearInstant_NonConsolidatedMember14000000JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember5575000000JPY
Tools furniture and fixturesCurrentYearInstant_NonConsolidatedMember5805000000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-4830000000JPY
Accumulated depreciation tools furniture and fixturesCurrentYearInstant_NonConsolidatedMember-5137000000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember745000000JPY
Tools furniture and fixtures netCurrentYearInstant_NonConsolidatedMember667000000JPY
LandPrior1YearInstant_NonConsolidatedMember8818000000JPY
LandCurrentYearInstant_NonConsolidatedMember8818000000JPY
Construction in progressPrior1YearInstant_NonConsolidatedMember246000000JPY
Construction in progressCurrentYearInstant_NonConsolidatedMember174000000JPY
Other ppePrior1YearInstant_NonConsolidatedMember15000000JPY
Other ppeCurrentYearInstant_NonConsolidatedMember12000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-03-31pass rounding
balance sheet identitynon_consolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass